Dr. Jeffrey D. White has been in the forefront of groundbreaking research on the etiology and treatment of HTLV-I associated adult T-cell leukemia/lymphoma. He is currently studying the natural history and treatment of cutaneous T-cell lymphoma in Bethesda, Maryland.
Previously, Dr. White was the Director, Clinical Trials and Clinical Care Program Metabolism Branch, at the National Cancer Institute in Bethesda. He was also a visiting professor at the Institute of Biomedical Sciences in Taipei, Taiwan 1993 and an Attending Physician at the Department of Internal Medicine at The Washington Hospital Center from 1991 – 1993.
Dr. White has given many invited lectures on the topics of complementary and alternative medicine and monoclonal antibody therapy at national and international medical conferences. He is certified in the subspecialties of Hematology and Medical Oncology by the American Board of Internal Medicine. He currently sits on the Medical Advisory Board of Gabrielle’s Angel Foundation and previously served on the Breast Health Advisory Council of the Susan G. Komen Breast Cancer Foundation.
Dr. White received a BS in Applied and Engineering Physics at Cornell University and his M.D. at Howard University College of Medicine. Additionally, he completed a residency in Internal Medicine and fellowships in hematology and medical oncology at The Washington Hospital Center.